Nir Sassi - 22 Dec 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Reporting relationship: Chief Financial Officer
Issuer ticker: INDP
Reported as of: 22 Dec 2025
Net transaction value: +$54,319
SEC form: 4
Accepted by SEC: 29 Dec 2025, 16:01:23 UTC
Prior SEC filing: 11 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Nir Sassi

Key filing fact

Nir Sassi filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 29 Dec 2025.

Key facts

This page summarizes Nir Sassi's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Dec 2025, 16:01.

Change

Previous filing in this sequence was filed on 11 Apr 2025.
Current net transaction value: +$54,319.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001760673 Primary reporting owner

Sassi Nir

Relationship: Chief Financial Officer
Address: C/O INDAPTUS THERAPEUTICS, INC, 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK
Signature: /s/ Nir Sassi
Signature date: 29 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INDP transaction

Common Stock

Award

Transaction value: $54,319
Shares: +26,758
Change %
Price: $2.03
Shares after: 26,758
Date: 22 Dec 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person acquired 26,758 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025.